Search - tctmd.com

Displaying 121 - 140 of 1870

Sort: Relevancy | Date

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

Yael L. Maxwell

September 10, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

Todd Neale

September 01, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Daily News

Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea

Todd Neale

August 27, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Opinion Editor's Corner

What’s Going to Be Hot at ESC 2024

Shelley Wood

August 23, 2024

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

L.A. McKeown

August 23, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

Caitlin E. Cox

July 11, 2024

News Daily News

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Caitlin E. Cox

June 25, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Risk of Death Remains Low a Decade After Primary PCI for STEMI

Caitlin E. Cox

June 18, 2024

News Daily News

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Yael L. Maxwell

June 14, 2024

Advertisement

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

More Support for Ticagrelor Monotherapy After PCI, Especially in ACS

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Edoxaban Monotherapy Wins for AF and Stable Coronary Disease: EPIC-CAD

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Dropping Aspirin From Post-LAAO Regimens Seems Like a Good Idea

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

What’s Going to Be Hot at ESC 2024

Platelet Hyperreactivity Score May Improve CVD Risk Detection

DES Best for In-Stent Restenosis, but DCBs Also Viable

August 2024 Dispatch for the CV Team

Ideal Aspirin Dose in Secondary Prevention Doesn’t Differ Much by Sex

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Risk of Death Remains Low a Decade After Primary PCI for STEMI

Benefits of 12-Month DAPT After CABG Persist to 5 Years: DACAB

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content